Risk of Cardiovascular Events in Patients with Type 2 Diabetes Treated With Exenatide BID or Other Glucose-Lowering Therapies: A Retrospective Analysis of the LifeLink™ Database

被引：0
|
作者：
Hoogwerf, Byron J.
Pelletier, Elise M.
Smith, Daniel B.
Best, Jennie H.
机构：
[1] Lilly USA LLC, Indianapolis, IN USA
[2] IMS Hlth, Watertown, MA USA
[3] IMS Healthcare, Watertown, MA USA
[4] Amylin Pharmaceut Inc, San Diego, CA USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Cardiovascular disease prevention; Type; 2; Diabetes; Glucose;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13242
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-of-the-Art Review
    Carbone, Salvatore
    Dixon, Dave L.
    Buckley, Leo F.
    Abbate, Antonio
    MAYO CLINIC PROCEEDINGS, 2018, 93 (11) : 1629 - 1647
  • [22] Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease
    Inzucchi, Silvio E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 137 - +
  • [23] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes
    Tomlinson, Brian
    Hu, Miao
    Zhang, Yuzhen
    Chan, Paul
    Liu, Zhong-Min
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (11) : 1267 - 1271
  • [24] New-Onset Atrial Fibrillation in Patients With Type 2 Diabetes Treated With Novel Glucose-Lowering Therapies
    Hsiao, Fu-Chih
    Yen, Kun-Chi
    Chao, Tze-Fan
    Chen, Shao-Wei
    Chan, Yi-Hsin
    Chu, Pao-Hsien
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09): : 2493 - 2499
  • [25] Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides
    Bailey, Clifford J.
    PEPTIDES, 2018, 100 : 9 - 17
  • [26] Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes
    Bilal, Anika
    Pratley, Richard E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (02) : 355 - 375
  • [27] Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes
    Starup-Linde, Jakob
    Gregersen, Soren
    Frost, Morten
    Vestergaard, Peter
    BONE, 2017, 95 : 136 - 142
  • [28] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
    Tomlinson, Brian
    Chan, Paul
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (04) : 175 - 179
  • [29] Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes
    Yudkin, John S.
    Vijan, Sandeep
    Sussman, Jeremy B.
    Lehman, Richard
    Goldacre, Ben M.
    LANCET, 2014, 384 (9948): : 1095 - 1095
  • [30] Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
    Ferrannini, Ele
    DeFronzo, Ralph A.
    EUROPEAN HEART JOURNAL, 2015, 36 (34) : 2288 - U19
12345